Loading...

A phase I study with an expanded cohort to assess the feasibility of intravenous paclitaxel, intraperitoneal carboplatin and intraperitoneal paclitaxel in patients with untreated ovarian, fallopian tube or primary peritoneal carcinoma: A Gynecologic Oncology Group study,,

OBJECTIVE: To define the maximum tolerated dose (MTD) and assess the feasibility of intravenous (IV) paclitaxel, intraperitoneal (IP) carboplatin, and IP paclitaxel in women with newly diagnosed Stages II–IV ovarian, fallopian tube, or primary peritoneal carcinoma. METHODS: Patients received escalat...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Gould, Natalie, Sill, Michael W., Mannel, Robert S., Thaker, P.H., DiSilvestro, Paul, Waggoner, Steve, Yamada, S. Diane, Armstrong, Deborah K., Wenzel, Lari, Huang, Helen, Fracasso, Paula M., Walker, Joan L.
Format: Artigo
Sprog:Inglês
Udgivet: 2011
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3670678/
https://ncbi.nlm.nih.gov/pubmed/22155262
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.12.417
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!